Abstract

Current medical diagnostics for systemic pathologies, which may rely on periodic and invasive clinical procedures, create a gap where sub-cellular shifts may progress undetected until physical symptoms manifest. Existing wearable biometric devices evaluate macro-level physiological lagging indicators and may lack the sensitivity to detect underlying atomic or chemical drivers of disease. Further, internal electromagnetic interference within consumer electronics may disrupt high-sensitivity quantum probes. This disclosure describes a computing device (the “device”) that utilizes a system-in-package containing synthetic diamond enriched with nitrogen-vacancy centers. A nested mu-metal shield encases the hardware to create a quiet zone, which allows the device to perform transcutaneous evaluation of bio-electric fields via the Stark effect and molecular magnetic resonances via hyperfine interaction. A neural bridge then processes these quantum signals to identify pathological signatures. This technology enables continuous clinical analysis of oncological and metabolic markers, allowing a user to transition from reactive treatment to proactive, sub-symptomatic health management.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS